Survey of use of anticoagulation in patients with atrial fibrillation.
作者信息
Bath P M, Prasad A, Brown M M, MacGregor G A
机构信息
Blood Pressure Unit, St George's Hospital Medical School, London.
出版信息
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
Abstract
摘要
相似文献
1
Survey of use of anticoagulation in patients with atrial fibrillation.
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
2
Underuse of anticoagulation in older patients with chronic atrial fibrillation: malpractice or accuracy?
J Am Geriatr Soc. 1999 Aug;47(8):1034-5. doi: 10.1111/j.1532-5415.1999.tb01303.x.
3
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med. 1994 Jul 11;154(13):1449-57.
4
Warfarin, aspirin, and atrial fibrillation.
Harv Heart Lett. 1998 Aug;8(12):4-6.
5
Anticoagulants for atrial fibrillation.
Med J Aust. 1992 Jul 20;157(2):77-8.
6
Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.
Arch Intern Med. 1999 Jul 26;159(14):1574-8. doi: 10.1001/archinte.159.14.1574.
7
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
BMJ. 1996 Jan 6;312(7022):45-9. doi: 10.1136/bmj.312.7022.45.
8
Recent national patterns of warfarin use in atrial fibrillation.
Circulation. 1998 Apr 7;97(13):1231-3. doi: 10.1161/01.cir.97.13.1231.
9
Warfarin use among patients with atrial fibrillation.
Stroke. 1997 Dec;28(12):2382-9. doi: 10.1161/01.str.28.12.2382.
10
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.
引用本文的文献
1
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
BMJ Open. 2019 Jul 24;9(7):e028387. doi: 10.1136/bmjopen-2018-028387.
2
Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation? A retrospective observational study.
Drugs Aging. 2010 Oct 1;27(10):807-13. doi: 10.2165/11537900-000000000-00000.
3
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.
CMAJ. 2007 May 22;176(11):1583-7. doi: 10.1503/cmaj.060837.
4
Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.
Clin Cardiol. 2004 Jan;27(1):40-6. doi: 10.1002/clc.4960270111.
5
Problems, interventions and complications in long-term oral anticoagulation therapy.
J Thromb Thrombolysis. 2002 Aug;14(1):65-72. doi: 10.1023/a:1022070406307.
6
Anticoagulants for atrial fibrillation: why is the treatment rate so low?
Clin Cardiol. 2002 Oct;25(10):447-54. doi: 10.1002/clc.4960251003.
7
Is warfarin really underused in patients with atrial fibrillation?
J Gen Intern Med. 2001 Nov;16(11):743-9. doi: 10.1111/j.1525-1497.2001.10432.x.
8
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators.
Heart. 1999 Nov;82(5):563-9. doi: 10.1136/hrt.82.5.563.
9
A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.
Br J Gen Pract. 1998 Nov;48(436):1775-8.
10
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units.
BMJ. 1998 Oct 17;317(7165):1041-6. doi: 10.1136/bmj.317.7165.1041.
本文引用的文献
1
Antithrombotic treatment and atrial fibrillation.
BMJ. 1993 Jan 16;306(6871):207. doi: 10.1136/bmj.306.6871.207-b.
2
Warfarin in chronic atrial fibrillation.
Lancet. 1993 May 29;341(8857):1376-7. doi: 10.1016/0140-6736(93)90945-d.
3
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.
BMJ. 1992 Dec 12;305(6867):1457-60. doi: 10.1136/bmj.305.6867.1457.
4
Antithrombotic treatment and atrial fibrillation.
BMJ. 1992 Dec 12;305(6867):1445-6. doi: 10.1136/bmj.305.6867.1445.
Zotero 插件